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Abstract In a clinical setting, molecular assays such as poly-
merase chain reaction offer a rapid means to infer or confirm
identity and therapeutic decisions. Accordingly, a number of
molecular assays targeting identity and antibiotic resistance
(AR) genes have been developed; however, these methods
can be technically complex and relatively expensive. Herein,
we describe a diagnostic concept utilizing isothermal amplifi-
cation technology with non-purified heat-lysed cells and self-
dispensing cards for testing multiple primers in parallel. This
proof-of-concept study, performed with Staphylococcus
aureus isolates and associated AR genes, was compared with
culture-based susceptibility and quantitative PCR (qPCR).
Results demonstrate reduced sample processing steps
resulting in a turnaround time (starting from bacterial culture
to ending in the antibiotic resistance gene profile) in less than
30 min. For antibiotics tested in which an associated AR gene
was targeted on the Gene-Z card, 69 % (18/26) of culture-
based resistance events were positive for related AR genes.
A comparison of loop-mediated isothermal amplification
(LAMP) and qPCR assays targeting the same antibiotic resis-
tance genes showed a 98.2 % agreement in terms of presence
and absence calls. Identity-based discrepancies between con-
ventional (phenotypic) and molecular (genotypic) results were
further resolved, and we were able to demonstrate higher ac-
curacy in identification with the molecular analysis.
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Introduction
Antibiotic resistance is a major public health problem world-
wide (ECDC and EMEA 2009; Freire-Moran et al. 2011;
French 2010; Gootz 2010; Levy and Marshall 2004; So et al.
2010; Spellberg et al. 2013). Infections caused by multidrug-
resistant (MDR) organisms result annually in an estimated 25,
000 deaths in Europe (29 countries) and 12,000 deaths in the
USA (TATFAR 2011). The situation in developing countries is
even worse (Byarugaba 2004; Okeke et al. 2005); for example,
in 2010, the World Health Organization (WHO) estimated that
650,000 out of 12 million cases of tuberculosis were MDR-TB
strains, in which case only slightly more than 50 % of patients
with MDR-TB are expected to be cured (Chan 2012).
The gap between the burden of infections due to
multidrug-resistant bacteria and the development of new
antibiotics is well documented (ECDC and EMEA 2009;
So et al. 2010; TATFAR 2011). It is also recognized that
the development of new drugs alone will not be sufficient
to address the growing resistance problem. Accordingly,
CDC proposed four core actions to reduce spread of
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antibiotic resistances. These include the prevention and
containment of infections, tracking resistant bacteria, im-
prove the use of antibiotics, and the development of new
antibiotics and new diagnostic tests for resistant bacteria
(CDC 2013).
Conventional antibiotic resistance (AR) detection methods,
e.g., broth dilution test, disk diffusion test, and automated
instrument systems (Jorgensen and Ferraro 2009), are based
on phenotypic characterization of isolated bacteria (suscepti-
bility testing) and thus require extended turnaround times
(Doern and Brecher 2011; Ledeboer and Hodinka 2011). Ac-
cordingly, molecular-based methods may offer a promising
means to confirm identity and therapeutics, even if principally
limited to detection of resistance determinants rather than sus-
ceptibility (Louie and Cockerill 2001). The US Food and
Drug Administration (FDA) has approved several PCR-
based tests for AR detection, including MRSA, vancomycin-
resistant Enterococcus spp., and rifampin-resistant Mycobac-
terium tuberculosis (Ledeboer and Hodinka 2011). Neverthe-
less, it has to be considered that numerous AR mechanisms
have been identified, and the number of involved genes is
accordingly high (Giedraitienė et al. 2011; Liu and Pop
2009). Therefore, a comprehensive detection method should
allow for significant multiplexing.
Accordingly, highly parallel microarray-based systems are
a possible solution. One of the first microarrays for the detec-
tion of AR genes was developed over 10 years ago (Call et al.
2003) and targeted 18 AR genes. Successively, more compre-
hensive systems were developed (Antwerpen et al. 2007;
Batchelor et al. 2008; Card et al. 2013; Dally et al. 2013; Frye
et al. 2006, 2010; Fu et al. 2012; Garneau et al. 2010;
McNicholas et al. 2011; Monecke and Ehricht 2005;Monecke
et al. 2012; Perreten et al. 2005; Strommenger et al. 2007; van
Hoek et al. 2005;Weile et al. 2007; Zhu et al. 2007). However,
none of these techniques are routinely used. Probable expla-
nation lies in the highly technical complexity of methods and
analysis. Standard microarray protocols include DNA extrac-
tion, DNA amplification and labeling, hybridization, washing,
scanning, and data analysis. These steps are time consuming
(at least several hours) and not easily automated. Furthermore,
the potential for error increases with each manual step. There-
fore, simpler and more rapid solutions are required for adop-
tion and routine use.
Gene-Z, a novel device for the point-of-care genetic test-
ing, combines multiplexing potential of the microarray
(Stedtfeld et al. 2012; Tourlousse et al. 2012) with simplicity
of loop-mediated isothermal amplification (LAMP). LAMP is
an established nucleic acid isothermal amplification method
offering rapid, accurate, and cost-effective detection (Mori
and Notomi 2009). LAMP utilizes four to six primers
targeting six to eight regions on the target gene, and two of
the primers (termed loop) are optionally used to reduce am-
plification time from 60–90 min to less than 30 min
(Nagamine et al. 2002). Strand displacement activity of Bst
polymerase and single-stranded loops generated by primer
structure allow amplification without temperature cycling.
High amplicon yield of LAMP permits detection with simple
optics or the naked eye (Tomita et al. 2008; Soli et al. 2013).
Furthermore, LAMP is more robust in terms of input material
and does not have sample preparation requirements compared
to PCR (Dugan et al. 2012).
In this study, we investigated the potential of using the
disposable self-dispensing cards developed for the Gene-Z
system for identification and profiling AR genes from bacte-
rial isolates with an emphasis on simplification of sample
preparation and time reduction. In detail, novel LAMP as-
says targeting AR genes were initially tested with both ref-
erence strains and 30 bacterial isolates using a conventional
real-time thermal cycler. The selected assays were subse-
quently screened with a second set of 11 bacterial isolates
using 64-well and 384-well disposable Gene-Z cards. Effi-
ciency of LAMP reactions was also tested with genomic
DNA (gDNA), cells, and crude lysates from the bacterial
isolates. Presence/absence calls of AR genes, determined
via visual inspection of time lapse images captured in real
time on the Gene-Z card, were compared to phenotypic iden-
tification methods and susceptibility. Gene-Z card results
were also compared with LAMP and qPCR run in vials
using a conventional real-time cycler.
Materials and methods
AR gene selection and LAMP primer design
Antibiotic Resistance Genes Database (ARDB, Liu and Pop
2009) was used to assemble a list of AR genes present in
Enterococcus faecalis, Enterococcus faecium, and Staphylo-
coccus aureus as of June 2010. For the proof-of-concept
study, gene selection was based on the following criteria: (i)
the number of journal articles found in PubMed when
searching for the gene name, (ii) the number of sequences
listed in ARDB (Liu and Pop 2009), (iii) the number of strains
in which the gene had been observed, (iv) coverage of a wide
range of AR gene categories, and (v) the ability to design
LAMP primers from the gene.
The web tool Primer Explorer (http://primerexplorer.jp/e/)
was used for LAMP primer design. One representative
sequence was initially used for primer design. Specificity
of designed primer sets was confirmed by BLAST analysis
(http://blast.ncbi.nlm.nih.gov/). For some primer sets,
degenerate bases were used to increase coverage. It
should be noted that primers were designed to be gene
specific, not species specific. As such, some primer sets
target AR genes present in species other than E. faecalis,
E. faecium, and S. aureus.
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Reference strains and bacterial isolates
Assay was initially tested using gDNA of bacterial reference
strains (Table 1) obtained from the American Type Culture
Collection (ATCC). Screening isolates were collected by
The Center for Comparative Epidemiology at the MSU Col-
lege of Veterinary Medicine. The first screening group
consisted of 30 isolates (10 isolates of each E. faecalis,
E. faecium, and S. aureus). A second screening group, which
was also subjected to culture-based susceptibility testing,
consisted of 11 S. aureus isolates (Table 2).
A microdilution system (Sensitire microdilution system,
TREK Diagnostic Systems Inc., Cleveland, OH, USA) was
used to perform antibiotic susceptibility testing (for a second
screening group) on a commercially prepared plate (GPN3F
Gram-positive MIC plate with tigecycline, TREK Diagnostic
Systems Inc., Cleveland, OH, USA). Ampicillin, oxacillin,
penicillin, ceftriaxone, ciprofloxacin, levofloxacin,
gatifloxacin, clindamycin, daptomycin, erythromycin, gentami-
cin, vancomycin, linezolid, quinupristin-dalfopristin, rifampin,
tetracycline, and trimethoprim-sulfamethoxazole were used in
susceptibility testing. Reference strains E. faecalis (ATCC
29212) and S. aureus (ATCC 29213) were used for quality
control purposes. Quality control results were reviewed for
each batch of tests, all of which were within acceptable limits.
Inducible clindamycin resistance was not investigated. A fluo-
rescence technology-based automated reading system
(AutoReader, TREK Diagnostic Systems Inc., Cleveland,
OH, USA) was used to generate antibiotic susceptibility and
resistance profiles (Table S2). Susceptibility, intermediate resis-
tance, and resistance were determined by comparison with
Clinical and Laboratory Standards Institute breakpoints (Clini-
cal and Laboratory Standards Institute 2007).
Template preparation
All strains were grown in trypticase soy broth (TSB) (211768,
BD Diagnostic Systems, Sparks, MD, USA) over night at
37 °C. Determination of colony forming units (CFU) was
done by drop-plating (Herigstad et al. 2001) ten-fold dilution
series in triplicate onto trypticase soy agar (TSA) (211042,
BD, Diagnostic Systems, Sparks, MD, USA).
Initial testing of primers sets with reference strains and the
first screening with isolates were performed with gDNA tem-
plates. Genomic DNAwas extracted using QIAGEN DNeasy
Blood and Tissue Kit (69504, QIAGEN, Valencia, CA, USA)
Table 1 Antibiotic resistance genes selected for LAMP primer design
Gene Resistance mechanism [gene ontology #] Antibiotic Target
organism(s)
Reference Strain





Spectinomycin, streptomycin E. faecalis A. baumannii (BAA-1710) 30
aadD Aminoglycoside nucleotidyltransferase
activity [GO:0034068]
Kanamycin, tobramycin S. aureus S. aureusMu50 (700699) 3
bacA Di-trans,poly-cis-decaprenylcistransferase
activity [GO:0008834]
Bacitracin E. faecalis, S. aureus S. aureusMu50 (700699) 153
bl2B_tem Beta-lactamase activity [GO:0008800] Cephalosporin, penicillin S. aureus E. fergusonii (35469) 34
ble Binding protein Bleomycin S. aureus S. aureusMu50 (700699) 5
cata9 Chloramphenicol O-acetyltransferase
activity [GO:0008811]
chloramphenicol E. faecium, S. aureus S. pneumoniae (700669) 5
dfra12 Dihydrofolate reductase activity [GO:0004146] Trimethoprim E. faecalis, S. aureus – 12




E. faecalis E. faecalis V583 (700802) 1
mphC Transferase activity, transferring
phosphorus-containing groups [GO:0016772]
Macrolide S. aureus – 2
mepA Multidrug efflux pump activity [GO:0015559] Tigecycline S. aureus S. aureusMu50 (700699) 1
norA Permease Fluoroquinolone S. aureus S. aureusMu50 (700699) 1
qacA MULTIDRUG efflux pump qa-compound S. aureus S. aureusMu50 (700699) 1
tetO Translation elongation factor activity [GO:0003746] Tetracycline E. faecalis S. pyogenes (12344) 16
tetM Translation elongation factor activity [GO:0003746] Tetracycline All S. aureusMu50 (700699) 33
vanG D-Alanine-D-alanine ligase activity [GO:0008716] Vancomycin E. faecalis – 1
vanB D-Alanine-D-alanine ligase activity [GO:0008716] Vancomycin E. faecalis, E. faecium S. aureusMu50 (700699) 5
vanA D-Alanine-D-alanine ligase activity [GO:0008716] Teicoplanin, vancomycin All – 5
vanYA D-alanine-D-alanine ligase activity [GO:0008716] Teicoplanin, vancomycin All – 4
vatA Acetyltransferase activity [GO:0016407] Streptogramin A S. aureus – 1
vgbA Lyase activity [GO:0016829] Streptogramin B S. aureus – 1
a Total number of genera that harbor the selected antibiotic resistance gene, as listed by ARDB (Liu and Pop 2009)
Appl Microbiol Biotechnol (2015) 99:7711–7722 7713
following the protocol for Gram-positive bacteria. DNA con-
centration was measured using QUBIT dsDNA BR Assay
(Q32850, Life Technologies, Grand Island, NY, USA) and
adjusted to 1 ng/μL.
The second screening of isolates was performed using
crude lysates. For this purpose, one colony from TSA plate
was re-suspended in 200 μL 1× PBS (P5493-1L, Sigma Al-
drich, St. Louis, MO, USA) and heat lysed at 95 °C for 5 min.
LAMP amplification
LAMP reactions were performed as described previously
(Stedtfeld et al. 2012). Briefly, reaction mixtures contained 1×
Bst DNA polymerase buffer (M0275L, New England Biolabs,
Ipswich, MA, USA), 1.4 mM of each dNTP (10297018, Life
Technologies, Grand Island, NY, USA), 800 mM betaine
(B0300, Sigma Aldrich, St. Louis, MO, USA), 6 mM MgSO4
(B1003S, New England Biolabs, Ipswich, MA, USA), 1×
primer mix (1.6 μM FIP and BIP, 800 nM LF and LB and
200 nM F3 and B3 primers), 1 mg/mL bovine serum albumin
(B9000S, New England Biolabs, Ipswich, MA, USA), 20 μM
SYTO-81 (S11362, Molecular Probes, Eugene, OR, USA
[product not available anymore, can be replaced with SYTO-
82, S11363, Life Technologies, Grand Island, NY, USA]),
0.2 % Pluronic F-68 (24040032, Life Technologies, Grand Is-
land, NY, USA), and 0.64 U/μL Bst DNA polymerase (large
fragment) (M0275L, New England Biolabs, Ipswich, MA,
USA). Reactions were performed with 1 ng gDNA or 1 μL
of cell lysate in 10 μL LAMP reaction.
Reactions were tested using a conventional real-time cycler
(Chromo4, BioRad Laboratories, Hercules, CA, USA) under
isotheral conditions or on Gene-Z cards. For on-card reac-
tions, 1 μL/well (64-well card) or 0.25 μL/well (384-well
card), 1× primer mix was dispensed and dehydrated directly
into card wells prior to assembly. For a 64-well card, 60-μL
reaction mixtures (including 1 μL template per 10 μL reaction
mix) were prepared and loaded per lane (16 reaction wells).
For 384-well card, 150-μL reaction mixtures (including 1 μL
template per 10 μL reaction mix) were prepared and loaded
into one of two inlets (192 reaction wells each).
All reactions were performed at 63 °C for 1 h with real-time
imaging; every 45 s in the real-time Chromo4 cycler and every
60 s on card using a CCD camera as described previously
(Ahmad et al. 2011; Tourlousse et al. 2012). Briefly, cards
were incubated on a digital heater (Labnet International Inc.,
Edison, NJ, USA). A 530-nm green LED (05027-PM12, LED
Supply, Randolph, VT, USA) was used to excite fluorescence,
and a 0.25-megapixel monochrome CCD camera (MEADE
DSI Pro, Irvine, CA, USA) with a 572 ± 20 nm bandpass filter
(FF01-572/2825, Semrock, Rochester, NY, USA) was used to
capture fluorescent emission.
Card fabrication
Cards were designed to allow for dispensing of sample into a
series of reaction wells without carryover of predispensed
primers (Stedtfeld and coauthors, submitted to Biomedical
Microdevices). Briefly, channels and wells were cut into 1.6-
Table 2 Culture-based antibiotic resistance and presence (+) and absence (−) of AR gene elements observed with LAMP assays tested on Gene-Z
cards with crude heat-lysed non-purified cell templates
Isolate number Phenotypic antibiotic resistance (MIC-μg/mL) LAMP assay (Tt, min)
norA ble tetM mecA nuc
S. aureus Mu50 Not tested +(27) +(21) +(18) +(22) +(20)
AR131 Amp (1), Pen (4), Rif (>4), Cli (>2), Ery (>4), Oxa (>8), Syn (>8), Tet (>16) − − +(21) − −
AR132 Amp (8), Pen (>8), Cip (>2), Ery (>4), Gat (4), Lev (8), Oxa (>8) +(30) − − +(24) +(24)
AR133 Pen (0.5), Cip (>2), Cli (>2), Ery (>4), Tet (>16) − − +(25) − −
AR134 Amp (>16), Pen (>8), Cef (>64), Cip (>2), Cli (>2), Ery (>4), Gat (8), Lev (>8), Oxa (>8) +(26) +(17) − +(18) +(22)
AR135 Amp (8), Pen (>8), Cef (>64), Cip (>2), Ery (>4), Gat (4), Lev (>8), Oxa (>8) +(30) +(19) − +(18) +(21)
AR136 Amp (>16), Pen (>8), Cef (>64), Cip (>2), Cli (>2), Ery (>4), Gat (>8), Lev (>8), Oxa (>8) +(29) +(18) − +(18) +(22)
AR137 Rif (>4), Cip (>2), Ery (>4), Gat (>8), Lev (>8), Syn (>4), Tet (>16), Tri (>4), Van (>128) +(35) − −a − +(22a)
AR139 Amp (>16), Pen (>8), Cef (>64), Cli (>2), Ery (>4), Gen (16), Oxa (>8) − − − +(26) −
AR141 Amp (>16), Pen (>8), Cef (>64), Cip (>2), Cli (>2), Ery (>4), Gat (>8), Lev (>8), Oxa (>8) +(31) +(16) −a +(22) +(21)
AR142 Amp (>16), Pen (>8), Cip (>2), Ery (>4), Gat (8), Lev (>8), Oxa (>8) +(41) +(31) − +(26) +(28)
AR143 Amp (>16), Pen (>8), Cef (>64), Cip (>2), Cli (>2), Ery (>4), Gat (8), Lev (>8), Oxa (>8) +(35) +(31) −a +(24) +(20)
Mean threshold time (Tt, min) for three replicate reactions is listed in parentheses
Amp ampicillin, Pen penicillin, Rif rifampin, Cli clindamycin, Ery erythromycin, Oxa oxacillin, Syn quinupristin-dalfopristin, Tet tetracycline, Cip
ciprofloxacin, Gat gatifloxacin, Lev levofloxacin, Cef ceftriaxone, Tri trimethoprim-sulfamethoxazole, Van vancomycin, Gen gentamicin
a Ambiguous results with endpoint image analysis; thus, images captured in real time were used for calls of presence and absence
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mm polymethyl methacrylate (PMMA) sheets (8560K173,
Mcmaster-Carr, Chicago, IL, USA) using a commercially
available desktop CO2 laser (MLE-40, Full Spectrum Laser
LLC, Las Vegas, NV, USA). The cutting power and speed of
the laser were varied to obtain desired depth and thickness of
channels and wells. Both 64-well and 384 well cards were
fabricated and tested for this study. For this study (Figs. 1a
and 2a), 64-well cards were fabricated with four separate
lanes, each with 16 wells, and 384-well cards were designed
with two lanes each with 196 wells. The volume of wells in
the 384-well cards was 0.4 μL. The sample volume for the 64-
well card (all four inlets) was 240μL (i.e., 60μL per inlet) and
for the 384-well card (including both inlets) was 300 μL.
After laser micromachining, the card was cleaned with 70 %
ethanol to remove PMMA residue and dried with filtered com-
pressed air to remove dust and other airborne particles. For cards
tested with LAMP, primers were dispensed into wells and
dehydrated by placing the card on a bench-top heater at 70 °C
for approximately 10min. Subsequently, engraved channels and
wells were enclosed via a biocompatible optical film with
pressure-sensitive adhesive (4311971, MicroAmp Optical Ad-
hesive Film; Applied Biosystems, Carlsbad, CA, USA). Secure
bonding of the film to PMMAwas ensured using a press (4386;
Carver, Wabash, IN, USA) at 3000 lb of pressure.
The card was loaded by first using a needle to pierce the
film above the loading port, followed by adding a sample
using a conventional 200-μL pipette. Pressure exerted by the
pipette pushed sample into the channels and reaction wells. In
this process, air inside the micro-channels was purged out
through a single air vent placed downstream from the series
of reaction wells. Fast-drying epoxy (SY-QS, Super Glue
Corp., Rancho Cucamonga, CA, USA) was used to seal inlet
and outlet (air) vents.
Gene-Z card versus qPCR assays
To compare Gene-Z results with more traditional molecular
methods, qPCR assays were tested with four of the isolates
(AR131, AR135, AR139, AR142) and S. aureus strain Mu50
using vials in a conventional real-time cycler (Chromo4,
BioRad Laboratories). Genes targeted for this comparison in-
cluded ant3ia, aadA, dfra12, mphC, qacA, tetM, and mecA
genes, in which qPCR primers were previously described
(Looft et al. 2012; Zhu et al. 2013). In addition, the F3 and
B3 LAMP primers were used as forward and reverse qPCR
primers for the norA, ble, nuc, and 16S ribosomal RNA
(rRNA) gene specific to S. aureus. qPCR was performed in
25-μL volumes and consisted of 500 nM forward and reverse
primers, 10 ng gDNA, and reagents from the Power SYBR
Green PCR Master Mix (Life Technologies). Real-time reac-
tions were run using the Chromo4 and included a 10-min
enzyme activation at 95 °C followed by 40 cycles of 95 °C
for 15 s and 60 °C for 60 s. A no-template control was includ-
ed for all assays, and all reactions were run in triplicate vials.
LAMP reactions were also tested in vials using the Chro-
mo4. LAMP reactions consisted of 0.4 μL per reaction cell
lysate on the Gene-Z card and 1 μL cell lysate per reaction in
vials on the Chromo4. For the Gene-Z card, primers were
dispensed in triplicate wells, and two lanes (each with 16
wells) were used per isolate. With this configuration, two iso-
lates were tested against ten assays with each Gene-Z card.
Gene-Z cards were monitored in real time using the Gene-Z
handheld device (Stedtfeld et al. 2012). Fluorescence of wells
was captured in 16-s intervals with the Gene-Z device and in
1-min intervals in the cycler. Temperature was maintained at
63 °C in both platforms.
Data analysis
Endpoint image analysis of Gene-Z cards consisted of
obtaining the signal intensities of the second (2 min) and last
image (60 min), which were extracted from 16-bit images
using ImageJ software package (http://rsbweb.nih.gov/ij/).
Absolute (ΔRn = S60 − S2) and relative (percent change =
S60/S2 * 100) signal changes were calculated using
Microsoft® Office Excel. Given the large differences in the
Fig. 1 Testing 64-well card with crude cell lysates of S. aureus isolates. a
Schematic diagram of 64-well Gene-Z card (four lane version for four
samples). b–c Fluorescence images of Gene-Z card after 60 min
amplification reactions for two of the tested cards. The layout of primers
dehydrated in the card during assembly and the identity of the samples
added in each array are indicated
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background intensity (S2 = 2–200), percent change was
considered to be a more reliable amplification indicator than
ΔRn. The large difference in background intensity caused
some ambiguity in making presence and absence calls based
solely on initial and endpoint image analysis. In these cases,
time lapse images taken during the amplification reaction was
used to confirm presence or absence and to determine
threshold time (Tt). An example of this ambiguity is
demonstrated in Fig S1. Overall, results were considered
positive if 2 out of 3 wells exhibited percent change value
greater than 115 % (i.e., signal increase of minimal 15 %).
This cutoff value is arbitrarily selected based on high
background of initial images.
For real-time analysis, qPCR threshold cycle (Ct) was
calculated as time in which the signal increased 0.01 (arbi-
trary units) above the original signal. For real-time analysis
of LAMP in Gene-Z cards and in vials, the threshold time
(Tt) was calculated as the time in which the signal in-
creased 0.01 and 0.03 (arbitrary units), respectively, above
the original signal.
16S rRNA gene PCR and sequencing
For ambiguities between phylogenetic and molecular assays,
further clarification was achieved via sequencing PCR
amplicons targeting the 16S rRNA gene. The 16S rRNA gene
w a s a m p l i f i e d u s i n g p r i m e r s F u 1 6 ( 5 ′
CCTACGGGAGGCAGCAG 3 ′ ) a n d Ru16 ( 5 ′
GACGTCRTCCNCDCCTTCCTC 3′) following previously
published protocols ( Khalaj-Kondori et al. 2007). Genomic
DNAwas isolated with QIAGEN DNeasy Blood and Tissue
Kit (69504, QIAGEN, Valencia, CA, USA) following the
protocol for Gram-positive bacteria. Amplicons were purified
using the QIAquick PCR purification Kit (28104, QIAGEN,
Valencia, CA, USA), and sequencing was performed by the
Research Technology Support Facility (RTSF) at Michigan
State University using the ABI 3730xl platform (Applied
Biosystems, Grand Island, NY, USA).
Based on the 16S rRNA gene amplicons, isolate AR 139
had 100 % sequence identity to Staphylococcus spp. (NCBI
accession number KF575164.1), isolate AR133 had 100 %
sequence similarity to Staphylococcus spp. (NCBI accession
number NR_102784.1), and isolate AR131 had 99.7 % se-
quence similarity to E. faecalis (NCBI accession number
KF193427.1). The partial 16S rRNA gene sequence from
AR131 was submitted to NCBI (KP824986).
Results
Design of AR gene LAMP assays
In total, 96AR genes were identified inE. faecalis,E. faecium,
and S. aureus (Table S3). Some genes were exclusive to one
organism of interest, whereas other genes were present in two
or three of the target organisms. Some genes are also not
specific to the three organisms examined in this study. Twenty
candidate target genes were selected for LAMP primer design
based on clinical and scientific relevance (Table 1, Table S1).
In two cases (cata9 and qacA), loop primer F (LF primer)
could not be designed.
Thirteen out of 20 LAMP assays were initially tested using
gDNA from ATCC (Table 1), and reactions were performed in
the Chromo4. Detection threshold times (Tt) ranged from 10 to
20 min using a 1-ng gDNA template (equivalent to 3.22 × 105
genome copies of S. aureus Mu50). Agreement between ex-
pected and experimental results was observed in terms of spec-
ificity and discrepancies were clarified. For example, S. aureus
Mu50 yielded positive results with aadD, bacA, ble, mepA,
norA, qacA, and tetM primer sets. With the exception of norA,
this is in agreement with the AR gene information on S. aureus
Mu50 listed in the ARDB (Liu and Pop 2009). While the norA
gene is not listed as one of the S. aureusMu50 AR genes in the
ARDB, cross-referencing with the complete genome sequence
of S. aureus Mu50 (NCBI accession number BA000017)
showed the norA gene is present in Mu50. Based on initial tests
Fig. 2 Real-time amplification curves for AR139 tested via a LAMP in
vials with heat-lysed non-purified cell template, b qPCR in vials with
gDNA template, and c LAMP on Gene-Z cards with heat-lysed non-
purified cell template. Solid black curves, gray curves, and dotted black
curves are assays targeting the 16S rRNA gene specific to S. aureus, qacA
gene, and mphC gene
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with reference strains, LAMP assays were used in isolate
screening experiments.
Minimal sample preparation
A comparative experiment was performed using gDNA, crude
heat-lysed non-purified cells, and native cells of S. aureus iso-
late AR132 as template. LAMP amplification was performed
using Chromo4. Results demonstrate LAMP can be performed
with minimal sample preparation of S. aureus isolates. Crudely
lysed cells had a lower Tt compared to native cells (Table S4,
Fig. S2), and both crude samples (native and lysed) yielded
lower Tt values compared to gDNA samples. This can be par-
tially explained by a smaller amount of template in reactions
tested with gDNA. In detail, plate counts of colony forming
units (CFU) showed reactions tested with native cells had ap-
proximately 5 × 105 CFU/μL. S. aureus has an average genome
size of 2.8 Mbp (Suzuki et al. 2012); 1 ng gDNA corresponds
to approximately 3.3 × 105 genome copies. As such, amplifi-
cation reactions performed with gDNA theoretically had a
slightly lower target number. In addition, plate counts do not
include extracellular DNA or non-viable cells.
Screening first group of isolates
Initial screening was performed with 30 isolates to further test
LAMP assays targeting AR genes and to aid in selection of
genes to test with Gene-Z card. Experiments were performed
using gDNA of S. aureus, E. faecalis, and E. faecium isolates
(10 each) and LAMP reactions were performed under stan-
dard reaction conditions (1 ng gDNA template, 10μL reaction
volume, real-time detection in Chromo4). Out of the seven
primer sets not initially tested with reference strains, four
targeting the mphC, vanA, vanYA, and vatA genes yielded
positive results with one or more of the isolates (Table S5).
Multiple resistance events were more common in S. aureus
isolates (10/10) than in E. faecalis (3/10) or E. faecium (5/10)
isolates. No AR genes were detected in six of the tested iso-
lates (two E. faecalis and four E. faecium), which may be a
result of investigating only a fraction of the genes listed in the
ARDB (20 out of 96).
Second group of isolates in Gene-Z cards, qPCR,
and susceptibility profiles
A second screening was performed with 11 S. aureus isolates
to demonstrate utility of the Gene-Z card for testing multiple
assays simultaneously and for comparing with culture-based
susceptibility. Cards were fabricated with 64 reaction wells
(Fig. 1a) and four individual loading ports and lanes. Gene-
Z cards were tested with heat-lysed non-purified cell tem-
plates. With this configuration, four samples (each with 16
reaction wells) were tested per card. Five different primer sets
were predispensed per sample lane in triplicate. Selected as-
says included norA, ble, and tetM and previously developed
mecA and nuc assays (Table S1). The nuc gene, a thermostable
nuclease of S. aureus, commonly used as a species-specific
marker (Brakstad et al. 1992) was included to confirm identi-
ty. The mecA assay (beta-lactam/methicillin resistance) was
included because of its importance in S. aureus antibiotic re-
sistance (Stefani et al. 2012; Wielders et al. 2002). Brighter
wells (e.g., all wells in the lane loaded with S. aureus Mu50)
following the 60-min reaction are considered positive ampli-
fication events (Fig. 1b, c). Summarized results for all of the
cards and isolates show a majority of the positive assays am-
plified after ~20–25 min (Table 2). The norA gene is the ex-
ception, amplifying around 30 min.
To compare Gene-Z card with more traditional molecular
methods (i.e., qPCR), four of the isolates (AR131, AR135,
AR139, and AR142) and S. aureus Mu50 were also tested
using LAMP (heat-lysed non-purified cell template) and
qPCR (gDNA) in vials run in a conventional real-time cycler
(Fig. 2). Overall, 100 % agreement was observed between
LAMP with Gene-Z card and LAMP in vials and 98.2 %
between and qPCR in vials (Table 3). Disagreement was ob-
served for the assay targeting the 16S rRNA genes specific to
S. aureus when tested with AR131, which amplified with
qPCR but not with LAMP. Sequencing of the 16S rRNA gene
showed the AR131 isolate had 99.7 % sequence similarity to
E. faecalis; thus, amplification with qPCR may have been a
lack of primer specificity. Probe match results obtained using
the Ribosomal Database Project (Cole et al. 2014) verified that
the qPCR primer designed to target the 16S rRNA gene of
S. aureus also targeted 77 sequences from Enterococcus.
Experiments with 384-well card
Considering results and 90 AR genes are present in these three
organisms tested (Table S3), it is clear the 64-well card may
not be sufficient for applications requiring more comprehen-
sive screening. Therefore, a 384-well card with self-
dispensing microfluidic channels was tested. Given the denser
architecture and reduced reaction volume compared to the 64-
well card, tests were performed to ensure no cross reactivity or
carryover of primers between wells. For this, the same five
primer sets used for the 64-well card were also used with the
384-well card. LAMP amplification was demonstrated with
both gDNA template (Fig. 3b) and lysed cells of S. aureus
Mu50. Positive/negative calls in the 384-well card correspond
to results observed on the 64-well card. Amplification time
was comparable to 64-well card, and no carryover of primer
or amplified product was observed between wells. One false-
positive signal (out of 192 wells) observed in a well loaded
with no template control (Fig. 3b) may be due to primer di-
mers; however, this is speculation as the amplicon was not
analyzed following the reaction.
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Discussion
LAMP assays screened with the 64-well Gene-Z card correct-
ly identified organisms originally misclassified via culturing.
In detail, three isolates (AR131, AR133, and AR139) previ-
ously identified as S. aureus tested negative for the LAMP
assay targeting the nuc gene. The nuc gene is a S. aureus-
specific marker (Brakstad et al. 1992), and accordingly, a pos-
itive result was expected for all isolates. The three isolates
were further tested using Staphylococcus spp.-specific 16S
LAMP assay (Table S1), and positive signals were only ob-
served with AR133 and AR139. To further clarify
Table 3 Presence and absence (−) of gene targeted assays observed with LAMP Gene-Z cards (crudely lysed cell template), LAMP in conventional
vials (crudely lysed cell template), and qPCR assays in conventional vials (gDNA template)
Isolate/Target aadA ble mecA mphC norA nuc qacA tetM 16S S. aureus
AR131
LAMP vial − − − − − − − 19.3 ± 3.0 -
qPCR vial − − − − − − − 15.3 ± 0.6 13.3 ± 0.6
LAMP Gene-Z − − − − − − − 14.0 ± 0.4 −
AR135
LAMP vial 26.6 ± 0.6 16.6 ± 0.6 15.3 ± 0.6 − 38.3 ± 0.6 17.0 ± 0.0 − − 15.6 ± 0.6
qPCR vial 14.0 ± 0.0 15.6 ± 0.6 16.6 ± 0.6 − 36.6 + 0.6 15.6 + 0.6 − − 12.3 ± 0.6
LAMP Gene-Z 16.4 ± 0.2 20.2 ± 0.7 18.2 ± 0.2 − 22.8 ± 0.2 14.8 ± 0.2 − − 16.8 ± 1.2
AR139
LAMP vial − − 15.6 ± 0.6 31.3 ± 0.6 − − 23.6 ± 0.6 − 15.6 ± 0.6
qPCR vial − − 16.6 ± 0.6 28.0 ± 0.0 − − 16.0 ± 0.0 − 12.6 ± 0.6
LAMP Gene-Z − − 26.3 ± 0.2 23.2 ± 1.1 − − 28.3 ± 1.2 − 14.6 ± 0.4
AR142
LAMP vial 26.3 ± 1.1 17.0 ± 1.0 15.3 ± 0.6 − 25.0 ± 0.0 17.3 ± 0.6 − − 16.0 ± 0.0
qPCR vial 17.0 ± 0.0 16.3 ± 0.6 17.0 ± 0.0 − 19.3 ± 1.5 15.3 + 0.6 − − 13.3 ± 0.6
LAMP Gene-Z 14.5 ± 0.2 18.2 ± 0.3 26.3 ± 0.2 − 24.0 ± 2.6 16.2 ± 0.2 − − 16.1 ± 0.3
S. aureus Mu50
LAMP vial 15.3 ± 0.6 12.3 ± 0.6 13.0 ± 0.0 − 19.6 ± 3.2 13.6 ± 0.6 19.0 ± 0.0 10.6 ± 0.6 13.0 ± 0.6
qPCR vial 15.3 ± 0.6 15.6 ± 0.6 19.3 ± 4.0 − 16.6 ± 0.6 16.3 ± 0.6 15.3 ± 0.6 15.6 ± 0.6 13.0 ± 0.0
LAMP Gene-Z 18.3 ± 1.1 17.9 ± 1.0 22.2 ± 0.6 − 17.8 ± 2.1 17.2 ± 1.8 27.0 ± 0.9 11.2 ± 0.6 11.8 ± 0.6
Mean threshold time (Tt, min) for three replicate reactions is listed with standard deviation. Assays targeting the ant3ia and dfra12 antibiotic resistant
genes did not amplify in all cases and are not included
Fig. 3 Testing 384-well card with gDNA of S. aureusMu50. a Schemat-
ic diagram of 384-well card (two-inlet version for two samples). b Fluo-
rescence image of 384-well card after 60 min amplification. The layout of
primers dehydrated in the card during assembly and composition of the
samples added in each array are indicated. The lone well with high signal
in the no-template control may be due to primer dimers as only 1 of 12
replicate wells showed amplification
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discrepancies, a partial 16S rRNA gene (675-bp fragment)
was PCR amplified and sequenced. Sequence analysis re-
vealed isolate AR131 is most related to E. faecalis (99.7 %
sequence homology to KF193427.1, new accession number
submitted KP824986). Isolates AR133 and AR139 are more
related to Staphylococcus intermedius/Staphylococcus
pseudintermedius (100 % sequence homology to
NR_102784.1) and Staphylococcus haemolyticus/Staphylo-
coccus epidermidis (100 % sequence homology to
KF575164.1), respectively. As such, the three isolates are
not S. aureus confirming the absence of the nuc gene as ob-
served with the LAMP assay.
LAMP assays screened with the 64-well Gene-Z card also
showed some agreement between culture-based susceptibility
tests and presence/absence of AR genes. Concerning only the
antibiotics tested in which related AR genes were targeted on
the Gene-Z card, 69 % (18/26) of culture-based resistance
events were positive for an associated AR gene (Table S6).
Resistance within the remaining eight events may be con-
veyed through other genes or mechanisms not targeted. In
addition, a negative amplification event resulted in 100 %
(15/15) correspondence with susceptibility.
For example, the norA gene encodes membrane-associated
multidrug efflux pump and conveys resistance to
(fluoro)quinolones (Tanaka et al. 2000). From tested antibi-
otics (Table 2), ciprofloxacin (Cip), gatifloxacin (Gat), and
levofloxacin (Lev) belong to the fluoroquinolone drug class.
Out of 11 tested isolates, nine were reported as fluoroquino-
lone resistant, eight isolates were resistant to all three tested
antibiotics, and AR133 was solely resistant to ciprofloxacin.
The norA gene amplified in eight isolates with multiple fluo-
roquinolone resistance (Cip + Gat + Lev). In isolate AR133,
norAwas not detected. However, ciprofloxacin resistance can
be mediated through different mechanisms (Campion et al.
2004; Tanaka et al. 2000), and therefore, it can be hypothe-
sized that resistance displayed by isolate AR133 was not due
to the presence of norA gene. As described above, isolate
AR133 is not S. aureus but rather a member of S. intermedius/
S. pseudintermedius group, which is not listed to harbor the
norA gene in the ARDB (Liu and Pop 2009).
Correspondence between the presence of tetM and mecA
genes as measured with the 64-well Gene-Z card and resis-
tance to associated antibiotics was also observed. The pres-
ence of the tetM gene was confirmed in two out of three
tetracycline-resistant isolates. Tetracycline resistance can be
conveyed by a number of genes. However, a majority of
S. aureus strains carry either the tetK or tetM gene (Liu and
Pop 2009). The tetM gene encodes a protein conferring resis-
tance to tetracycline by interacting with the ribosome and
promoting the release of bound tetracycline (Ito et al. 2003).
Isolate AR137 may only harbor the tetK gene instead of the
tetM gene. The presence of the mecA gene was confirmed in
eight of the ten isolates that showed resistance to associated
antibiotics. The mecA gene encodes penicillin binding protein
(PBP2) and is accordingly involved in beta-lactam and con-
sequently in methicillin resistance (Vannuffel et al. 1995).
Even though, methicillin susceptibility was not tested, data
was available for a range of other beta-lactam antibiotics in-
cluding ampicillin (Amp), penicillin (Pen), and oxacillin
(Oxa) (Hamilton et al. 2012). Ten out of 11 tested isolates
showed beta-lactam resistance, nine isolates were resistant to
all three tested antibiotics, and AR133 was solely resistant to
penicillin. The mecA gene was observed absent for isolates
AR131, AR133, and AR137. Isolate AR137 is susceptible
to all tested beta-lactams, and therefore, this result is expected
(true negative). In isolates AR131 and AR133, beta-lactam
resistance may be conveyed through other genes or
mechanisms.
The presence of the ble gene was observed in 6 out of the
11 isolates tested with the Gene-Z card. Since bleomycine
resistance was not tested (Hamilton et al. 2012), results of
LAMP assays could not be compared to phenotypic profiles.
The ble gene encodes binding protein with a strong affinity to
the bleomycin family of antibiotics (Gennimata et al. 1996),
which was included due to high incidence in screening initial
isolates (9/10 S. aureus isolates).
Overall, screening results demonstrate the 64-well and 384-
well Gene-Z cards and LAMP amplification are simple and
rapid methods for multiple target isolate identification and
screening of AR genes. The main benefit of this protocol is
30 min time to results. Including heat lysis step, reagent prep-
aration, loading and sealing the card, and the typical ~20-min
reaction time, the assay can be performed in less than 30 min.
Results (Table S3) indicate non-lysed S. aureus cell template
can be used directly with LAMP; thus in some instances, lysis
may be unnecessary. If lysis is omitted and reagents are
premixed, the assay can potentially be performed in under
25 min. PCR-based assays that require sample processing will
necessitate more time and in some instances testing in an off-
site diagnostics laboratory.
Additional advantages of LAMP integrated with the Gene-
Z cards include (i) cost benefit, (ii) multiple assays in parallel,
and (iii) size. Overall cost per sample is estimated to be $13
USDwhen using 384-well card, corresponding to 10 cents per
test (with triplicate replications), with ~15 % of this cost from
card material and fabrication and remaining percentage asso-
ciated with reagent costs. Costs outside of an academic labo-
ratory will increase for good manufacturing practices and
quality control.
The footprint of the device and simplicity of minimal sam-
ple processing with LAMP offers the possibility of point of
care, while the microfluidic self-dispensing Gene-Z cards can
screen for multiple organism and AR genes in parallel. Devel-
opment of a more comprehensive set of assays that focus on
specific infections (e.g., blood- or urine-based assays) will add
utility to the Gene-Z device for LAMP diagnostics in a clinical
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setting. For example, a user could design cartridges with as-
says to identify the 20 most common organisms responsible
for ~90 % of septic infections and also target AR genes asso-
ciated with resistance in a high percentage of those organisms.
It should be acknowledged that molecular-based assays could
fail to identify an infectious organism due to exclusion or
incomplete coverage of primers, or instances in which the
presence or absence of an AR gene does not correspond with
susceptibility.
Taken together, DNA-based molecular detection of AR
genes cannot replace culture-based susceptibility tests. The
molecular presence and absence of AR genes can only offer
inferences towards a potential means or confirmation of treat-
ment. This is particularly useful when DNA-based means of
detection are simple, rapid, and offer testing for difficult-to-
culture microorganisms such as Mycobacterium and
Chlamydia. A RNA-based approach with a brief pulse of an-
tibiotics followed by the identification of transcripts (Barczak
et al. 2012) using RT-LAMP (Rudolph et al. 2015) and the
Gene-Z card or similar devices may provide molecular results
equivalent to susceptibility testing.
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